<DOC>
	<DOCNO>NCT02593357</DOCNO>
	<brief_summary>The aim study assess peripheral endothelial function adult COPD ( chronic obstructive pulmonary disease ) patient relationship peripheral endothelial function pulmonary function .</brief_summary>
	<brief_title>Peripheral Endothelial Function COPD Patients</brief_title>
	<detailed_description>The primary criterion peripheral endothelial function assess measure flow-mediated dilation ( reactive hyperemia-peripheral artery tone index ) . The pulmonary function assess measure FEV1 ( forced expiratory volume one second ) , force vital capacity ( FVC ) expiratory flow 25 % 75 % ( FEF25-75 % ) . The relationship parameter pulmonary function peripheral endothelial function analyze . In addition , relationship peripheral endothelial function severity COPD ( classification accord GOLD ( Global Initiative Chronic Obstructive Lung Disease ) 2010 GOLD 2011 COPD assessment test , cardiovascular risk factor ( SCORE INdex ) smoker status also assess .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>COPD : FEV1/FVC &lt; 70 % Smokers exsmokers ( â‰¥ 10 packyears ) No COPD exacerbation last three month No history asthma respiratory allergy Pregnant nursing woman Treatment pulmonary vasodilator Patients significant acute disease . A significant disease define disease , opinion investigator , may influence result trial .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>COPD</keyword>
	<keyword>pulmonary function</keyword>
</DOC>